Report Detail
Global Non-Animal Softgel Capsules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4667185 |
- 21 July, 2026 |
- Global |
- 108 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Non-Animal Softgel Capsules market size was valued at US$ 469 million in 2025 and is forecast to a readjusted size of US$ 652 million by 2032 with a CAGR of 4.9% during review period.
Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.
Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world. Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively. Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales. This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.
This report is a detailed and comprehensive analysis for global Non-Animal Softgel Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-Animal Softgel Capsules market size and forecasts, in consumption value ($ Million), sales quantity (M Capsules), and average selling prices (US$/Capsule), 2021-2032
Global Non-Animal Softgel Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Capsules), and average selling prices (US$/Capsule), 2021-2032
Global Non-Animal Softgel Capsules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Capsules), and average selling prices (US$/Capsule), 2021-2032
Global Non-Animal Softgel Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (M Capsules), and ASP (US$/Capsule), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Animal Softgel Capsules
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Animal Softgel Capsules market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, Sofgen Pharma, Ourvita (HBI EuroCaps), Sirio Pharma, Aenova, Captek, Bahrain Pharma, Robinson Pharma, Aland, Fuji Capsule, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-Animal Softgel Capsules market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Carrageenan Softgel
Starch Softgel
Gellan Gum Softgel
Market segment by Function
Vitamins and Minerals
Fish Oil and Algae Oil
Coenzyme Q10 and Lutein
Pharma
Other
Market segment by Marketing Method
Direct Sales
Distribution
Market segment by Application
Health Supplements
Pharmaceutical
Others
Major players covered
Catalent
Sofgen Pharma
Ourvita (HBI EuroCaps)
Sirio Pharma
Aenova
Captek
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
KD Nutra
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Animal Softgel Capsules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-Animal Softgel Capsules, with price, sales quantity, revenue, and global market share of Non-Animal Softgel Capsules from 2021 to 2026.
Chapter 3, the Non-Animal Softgel Capsules competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Animal Softgel Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-Animal Softgel Capsules market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-Animal Softgel Capsules.
Chapter 14 and 15, to describe Non-Animal Softgel Capsules sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Non-Animal Softgel Capsules Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Carrageenan Softgel
- 1.3.3 Starch Softgel
- 1.3.4 Gellan Gum Softgel
- 1.4 Market Analysis by Function
- 1.4.1 Overview: Global Non-Animal Softgel Capsules Consumption Value by Function: 2021 Versus 2025 Versus 2032
- 1.4.2 Vitamins and Minerals
- 1.4.3 Fish Oil and Algae Oil
- 1.4.4 Coenzyme Q10 and Lutein
- 1.4.5 Pharma
- 1.4.6 Other
- 1.5 Market Analysis by Marketing Method
- 1.5.1 Overview: Global Non-Animal Softgel Capsules Consumption Value by Marketing Method: 2021 Versus 2025 Versus 2032
- 1.5.2 Direct Sales
- 1.5.3 Distribution
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Non-Animal Softgel Capsules Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Health Supplements
- 1.6.3 Pharmaceutical
- 1.6.4 Others
- 1.7 Global Non-Animal Softgel Capsules Market Size & Forecast
- 1.7.1 Global Non-Animal Softgel Capsules Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Non-Animal Softgel Capsules Sales Quantity (2021-2032)
- 1.7.3 Global Non-Animal Softgel Capsules Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Catalent
- 2.1.1 Catalent Details
- 2.1.2 Catalent Major Business
- 2.1.3 Catalent Non-Animal Softgel Capsules Product and Services
- 2.1.4 Catalent Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Catalent Recent Developments/Updates
- 2.2 Sofgen Pharma
- 2.2.1 Sofgen Pharma Details
- 2.2.2 Sofgen Pharma Major Business
- 2.2.3 Sofgen Pharma Non-Animal Softgel Capsules Product and Services
- 2.2.4 Sofgen Pharma Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Sofgen Pharma Recent Developments/Updates
- 2.3 Ourvita (HBI EuroCaps)
- 2.3.1 Ourvita (HBI EuroCaps) Details
- 2.3.2 Ourvita (HBI EuroCaps) Major Business
- 2.3.3 Ourvita (HBI EuroCaps) Non-Animal Softgel Capsules Product and Services
- 2.3.4 Ourvita (HBI EuroCaps) Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Ourvita (HBI EuroCaps) Recent Developments/Updates
- 2.4 Sirio Pharma
- 2.4.1 Sirio Pharma Details
- 2.4.2 Sirio Pharma Major Business
- 2.4.3 Sirio Pharma Non-Animal Softgel Capsules Product and Services
- 2.4.4 Sirio Pharma Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Sirio Pharma Recent Developments/Updates
- 2.5 Aenova
- 2.5.1 Aenova Details
- 2.5.2 Aenova Major Business
- 2.5.3 Aenova Non-Animal Softgel Capsules Product and Services
- 2.5.4 Aenova Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Aenova Recent Developments/Updates
- 2.6 Captek
- 2.6.1 Captek Details
- 2.6.2 Captek Major Business
- 2.6.3 Captek Non-Animal Softgel Capsules Product and Services
- 2.6.4 Captek Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Captek Recent Developments/Updates
- 2.7 Bahrain Pharma
- 2.7.1 Bahrain Pharma Details
- 2.7.2 Bahrain Pharma Major Business
- 2.7.3 Bahrain Pharma Non-Animal Softgel Capsules Product and Services
- 2.7.4 Bahrain Pharma Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Bahrain Pharma Recent Developments/Updates
- 2.8 Robinson Pharma
- 2.8.1 Robinson Pharma Details
- 2.8.2 Robinson Pharma Major Business
- 2.8.3 Robinson Pharma Non-Animal Softgel Capsules Product and Services
- 2.8.4 Robinson Pharma Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Robinson Pharma Recent Developments/Updates
- 2.9 Aland
- 2.9.1 Aland Details
- 2.9.2 Aland Major Business
- 2.9.3 Aland Non-Animal Softgel Capsules Product and Services
- 2.9.4 Aland Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Aland Recent Developments/Updates
- 2.10 Fuji Capsule
- 2.10.1 Fuji Capsule Details
- 2.10.2 Fuji Capsule Major Business
- 2.10.3 Fuji Capsule Non-Animal Softgel Capsules Product and Services
- 2.10.4 Fuji Capsule Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Fuji Capsule Recent Developments/Updates
- 2.11 Sunsho Pharmaceutical
- 2.11.1 Sunsho Pharmaceutical Details
- 2.11.2 Sunsho Pharmaceutical Major Business
- 2.11.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product and Services
- 2.11.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Sunsho Pharmaceutical Recent Developments/Updates
- 2.12 KD Nutra
- 2.12.1 KD Nutra Details
- 2.12.2 KD Nutra Major Business
- 2.12.3 KD Nutra Non-Animal Softgel Capsules Product and Services
- 2.12.4 KD Nutra Non-Animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 KD Nutra Recent Developments/Updates
3 Competitive Environment: Non-Animal Softgel Capsules by Manufacturer
- 3.1 Global Non-Animal Softgel Capsules Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Non-Animal Softgel Capsules Revenue by Manufacturer (2021-2026)
- 3.3 Global Non-Animal Softgel Capsules Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Non-Animal Softgel Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Non-Animal Softgel Capsules Manufacturer Market Share in 2025
- 3.4.3 Top 6 Non-Animal Softgel Capsules Manufacturer Market Share in 2025
- 3.5 Non-Animal Softgel Capsules Market: Overall Company Footprint Analysis
- 3.5.1 Non-Animal Softgel Capsules Market: Region Footprint
- 3.5.2 Non-Animal Softgel Capsules Market: Company Product Type Footprint
- 3.5.3 Non-Animal Softgel Capsules Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Non-Animal Softgel Capsules Market Size by Region
- 4.1.1 Global Non-Animal Softgel Capsules Sales Quantity by Region (2021-2032)
- 4.1.2 Global Non-Animal Softgel Capsules Consumption Value by Region (2021-2032)
- 4.1.3 Global Non-Animal Softgel Capsules Average Price by Region (2021-2032)
- 4.2 North America Non-Animal Softgel Capsules Consumption Value (2021-2032)
- 4.3 Europe Non-Animal Softgel Capsules Consumption Value (2021-2032)
- 4.4 Asia-Pacific Non-Animal Softgel Capsules Consumption Value (2021-2032)
- 4.5 South America Non-Animal Softgel Capsules Consumption Value (2021-2032)
- 4.6 Middle East & Africa Non-Animal Softgel Capsules Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Non-Animal Softgel Capsules Sales Quantity by Type (2021-2032)
- 5.2 Global Non-Animal Softgel Capsules Consumption Value by Type (2021-2032)
- 5.3 Global Non-Animal Softgel Capsules Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Non-Animal Softgel Capsules Sales Quantity by Application (2021-2032)
- 6.2 Global Non-Animal Softgel Capsules Consumption Value by Application (2021-2032)
- 6.3 Global Non-Animal Softgel Capsules Average Price by Application (2021-2032)
7 North America
- 7.1 North America Non-Animal Softgel Capsules Sales Quantity by Type (2021-2032)
- 7.2 North America Non-Animal Softgel Capsules Sales Quantity by Application (2021-2032)
- 7.3 North America Non-Animal Softgel Capsules Market Size by Country
- 7.3.1 North America Non-Animal Softgel Capsules Sales Quantity by Country (2021-2032)
- 7.3.2 North America Non-Animal Softgel Capsules Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Non-Animal Softgel Capsules Sales Quantity by Type (2021-2032)
- 8.2 Europe Non-Animal Softgel Capsules Sales Quantity by Application (2021-2032)
- 8.3 Europe Non-Animal Softgel Capsules Market Size by Country
- 8.3.1 Europe Non-Animal Softgel Capsules Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Non-Animal Softgel Capsules Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Non-Animal Softgel Capsules Market Size by Region
- 9.3.1 Asia-Pacific Non-Animal Softgel Capsules Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Non-Animal Softgel Capsules Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Non-Animal Softgel Capsules Sales Quantity by Type (2021-2032)
- 10.2 South America Non-Animal Softgel Capsules Sales Quantity by Application (2021-2032)
- 10.3 South America Non-Animal Softgel Capsules Market Size by Country
- 10.3.1 South America Non-Animal Softgel Capsules Sales Quantity by Country (2021-2032)
- 10.3.2 South America Non-Animal Softgel Capsules Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Non-Animal Softgel Capsules Market Size by Country
- 11.3.1 Middle East & Africa Non-Animal Softgel Capsules Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Non-Animal Softgel Capsules Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Non-Animal Softgel Capsules Market Drivers
- 12.2 Non-Animal Softgel Capsules Market Restraints
- 12.3 Non-Animal Softgel Capsules Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Non-Animal Softgel Capsules and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Non-Animal Softgel Capsules
- 13.3 Non-Animal Softgel Capsules Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Non-Animal Softgel Capsules Typical Distributors
- 14.3 Non-Animal Softgel Capsules Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Non-Animal Softgel Capsules. Industry analysis & Market Report on Non-Animal Softgel Capsules is a syndicated market report, published as Global Non-Animal Softgel Capsules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Non-Animal Softgel Capsules market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
